banner image

SHIL welcomes new cohort of junior doctors

As the future of the NHS and a critical part of the teams providing safe care and treatment to patients, SHIL is encouraging new first-year foundation doctors (FY1s) to drive change, innovation and improvement

SHIL welcomes new cohort of junior doctors  image

As new first-year foundation doctors (FY1s) are welcomed on wards across NHS Scotland, Scottish Health Innovations Ltd. (SHIL) is encouraging them to look for new ways to drive change, innovation and improvement.

After completing medical school, junior doctors complete a two-year foundation programme in both hospitals and primary care, where they experience multiple areas of practice. After these two years, they will decide their next steps as a doctor and may embark upon specialty training, core training or training as a GP.

As they embark on this exciting new step in their careers, there are opportunities to inspire and shape the future of NHS health and social care. The expertise and support of SHIL can help on this journey, accelerating new and innovative ideas into viable products and services to improve patient care.

“We warmly welcome the new doctors starting out in their careers – they are the future of the NHS. The team here at SHIL have decades of experience helping health and social care professionals accelerate innovative ideas into commercial reality. We welcome all new ideas and fresh thinking as we work collaboratively to shape a bold and innovative NHS.”

Graham Watson, Executive Chairman, SHIL

A number of junior doctors have taken forward a range of innovative projects which are making an impact across Scotland and beyond. These include:

  • Snap 40 enables health services to safely keep patients at home. Using a single medical-grade wearable device, discreetly worn on the upper arm, the device continuously monitors a patient in the hospital, in their own home and out in the community across more vital signs than any other single wearable device on the market. This includes blood pressure (without the use of an inflatable cuff), respiratory rate, heart rate, mobility, oxygen saturation, temperature and perspiration. The device was created by NHS Tayside medical student Chris McCann
  • Ward Watch is a new way of managing access to, and delivery of, clinical learning, teaching and data collection. It is a platform that connects students and other clinical staff with learning opportunities around the hospital in real-time while allowing teachers and supervisors’ oversight and control. It was created by final year medical students in NHS Tayside
  • Dr Flint is s the first clinically validated opioid converter in clinical practice. The SPOT platform is a new medical device. A clinician-led, clinically validated, CE-marked clinician decision support tool, SPOT is proven to significantly improve the confidence of opioid prescribing in users and adherence to best practice guidelines. It has been developed in partnership with the University of Dundee, NHS Tayside, The Digital Health and Care Institute, Scottish Enterprise and Innovate UK
  • EnteroBiotix is a leading microbiome therapeutics company with a vision to transform the standard of care for patients suffering from substantial unmet clinical needs through microbiome modulating therapeutics; and in doing so, create a sustainable pharmaceutical company. Dr James McIlroy founded the company in 2017 while working as junior doctor in NHS Grampian
  • Javelin Health is an award-winning healthcare technology start-up operating within the cardiovascular market. Based in Scotland, the company works with technology, clinical and academic partners to develop and commercialise product solutions to pressing unmet clinical needs. Ashton Barnett-Vanes, who works in the Department of Emergency Medicine in NHS Lothian has been awarded the prestigious Enterprise Fellowship award to aid future work

“These examples are just a snapshot of some of the innovative projects to originate from junior doctors across Scotland. We know life as a junior doctor is busy and our support is designed to alleviate some of that pressure by taking care of the protection of ideas, regulatory considerations, project management, manufacturing and commercialisation. The fusion of knowledge, ideas, and skills is vital and we are committed to accelerating innovative ideas that not only improve patient care but offer wider economic and social benefits to Scotland.”

Dr Robert Rea, Head of Innovation, SHIL

More information

Back to Blog

This post has 0 comments

Add comment